慢性鼻炎与鼻和生物药物:呼吁在临床研究中更好地标准化和呈现数据
Harsha Hemantha Kariyawasam1,2, Dean Langan3, Joanne Rimmer4,5,6
1Specialist Allergy and Clinical Immunology, Royal National ENT Hospital, London, UK.
Therapeutics and clinical risk management
|January 13, 2025
概括
在慢性鼻炎与鼻息肉 (CRSwNP) 中对生物药物的临床试验进行标准化至关重要. 改进的试验设计和数据呈现将增强元分析,以获得更好的治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 临床试验 临床试验
背景情况:
- 带有鼻息肉的慢性鼻炎 (CRSwNP) 存在重大治疗挑战.
- 针对炎症途径的生物药物显示出对CRSwNP管理的希望.
- 在CRSwNP中对生物制剂的现有随机对照试验 (RCT) 需要标准化,以便进行可靠的元分析.
研究的目的:
- 强调需要在CRSwNP中对生物药物的双盲RCT进行更好的标准化.
- 解决目前RCT设计中阻碍元分析的局限性.
- 倡导标准化方法,以促进生物制剂的比较疗效评估.
主要方法:
- 在CRSwNP中对生物药物的现有RCT进行系统审查和元分析.
- 对研究设计,患者选择,治疗持续时间,结果测量和数据呈现的批判性评估.
- 识别跨研究的异质性和数据提取挑战.
主要成果:
- 由于研究设计和患者选择标准不一致,在RCT中观察到显著的异质性.
- 治疗持续时间和结果措施的变化使比较疗效评估复杂化.
- 数据呈现不清楚,需要将一些数据集和RCT从元分析中排除在外.
结论:
- 在CRSwNP中对生物制剂的未来RCT标准化方面迫切需要改进.
- 标准化数据呈现对于促进元分析的清晰和可提取数据至关重要.
- 标准化的RCT将使更强大的元分析成为可能,从而更好地识别受益于特定生物制剂和改善临床结果的患者子组.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:23Chronic Pharyngitis
1.1K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
01:30Epistaxis
123
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
123
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217